HUP0300273A2 - Eljárás 5-szubsztituált 1-(4-fluorfenil)-1,3-dihidroizobenzofurán-származékok lépésenkénti alkilezésére - Google Patents
Eljárás 5-szubsztituált 1-(4-fluorfenil)-1,3-dihidroizobenzofurán-származékok lépésenkénti alkilezéséreInfo
- Publication number
- HUP0300273A2 HUP0300273A2 HU0300273A HUP0300273A HUP0300273A2 HU P0300273 A2 HUP0300273 A2 HU P0300273A2 HU 0300273 A HU0300273 A HU 0300273A HU P0300273 A HUP0300273 A HU P0300273A HU P0300273 A2 HUP0300273 A2 HU P0300273A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- hydrogen atom
- general formula
- formula
- alkyl group
- Prior art date
Links
- -1 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans Chemical class 0.000 title 1
- 230000029936 alkylation Effects 0.000 title 1
- 238000005804 alkylation reaction Methods 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 3
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 229960001653 citalopram Drugs 0.000 abstract 2
- WSEQXVZVJXJVFP-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile Chemical compound O1CC2=CC(C#N)=CC=C2C1(CCCN(C)C)C1=CC=C(F)C=C1 WSEQXVZVJXJVFP-UHFFFAOYSA-N 0.000 abstract 1
- 101100516554 Caenorhabditis elegans nhr-5 gene Proteins 0.000 abstract 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002971 oxazolyl group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 125000003003 spiro group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/10—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Abstract
A találmány tárgya eljárás á jól ismert antidepresszáns hatásúcitalopram, azaz 1-[3-(dimetilamino)propil]-1-(4-fluorfenil)-1,3-dihidro-5-izobenzofuránkarbonitril előállítására. A találmányértelmében úgy járnak el, hogy valamely (I) általános képletűvegyületet - a képletben R jelentése halogénatom, cianocsoport,hidroxilcsoport, O-triflát-csoport, NHR5 általános képletű csoport(ebben a képletben R5 jelentése hidrogénatom vagy tartalmazóalkilkarbonilcsoport), formilcsoport, CO2R6 vagy CONHR7 általánosképletű csoport (ezekben a képletekben R6 és R7 egymástól függetlenülhidrogénatomot vagy alkilcsoportot jelent) vagy (II) általános képletűoxazolil- vagy tiazolilcsoport (ebben a képletben U jelentése oxigén-vagy kénatom, R1 és R2 egymástól függetlenül hidrogénatomot vagyalkilcsoportot jelent vagy R1 és R2 együtt alkilénláncot alkotnak ésígy spiro-gyűrűt képeznek, R3 jelentése hidrogénatom vagyalkilcsoport, R4 jelentésre hidrogénatom, alkilcsoport,karboxilcsoport vagy az utóbbi valamelyik prekurzorcsoportja, vagy R3és R4 együtt alkilénláncot jelentenek és így spirogyűrűt alkotnak) -reagensek lépésenkénti adagolása útján olyan reagáltatásoknak vetikalá, hogy a citalopram 3-(N,N-dimetilamino)-prop-1-il-szubsztituensekialakuljon, és adott esetben - ha R jelentése cianocsoporttól eltérő- a reakciósorozat egy alkalmas időpontjában R helyettesítőtcianocsoporttá alakítják. Ó
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200000403 | 2000-03-13 | ||
| DKPA200000414 | 2000-03-14 | ||
| PCT/DK2001/000159 WO2001068629A1 (en) | 2000-03-13 | 2001-03-09 | Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0300273A2 true HUP0300273A2 (hu) | 2003-06-28 |
Family
ID=26068792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0300273A HUP0300273A2 (hu) | 2000-03-13 | 2001-03-09 | Eljárás 5-szubsztituált 1-(4-fluorfenil)-1,3-dihidroizobenzofurán-származékok lépésenkénti alkilezésére |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6864379B2 (hu) |
| EP (1) | EP1265881A1 (hu) |
| JP (1) | JP2003527385A (hu) |
| KR (1) | KR20020080485A (hu) |
| CN (1) | CN1427835A (hu) |
| AU (1) | AU2001239210A1 (hu) |
| BG (1) | BG107046A (hu) |
| BR (1) | BR0109364A (hu) |
| CA (1) | CA2402553A1 (hu) |
| CZ (1) | CZ20023100A3 (hu) |
| EA (1) | EA200200968A1 (hu) |
| HR (1) | HRP20020758A2 (hu) |
| HU (1) | HUP0300273A2 (hu) |
| IL (1) | IL151566A0 (hu) |
| IS (1) | IS6530A (hu) |
| MX (1) | MXPA02008684A (hu) |
| NO (1) | NO20024352L (hu) |
| NZ (1) | NZ521204A (hu) |
| PL (1) | PL357022A1 (hu) |
| SK (1) | SK14522002A3 (hu) |
| TR (1) | TR200202195T2 (hu) |
| WO (1) | WO2001068629A1 (hu) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE237604T1 (de) * | 1999-04-14 | 2003-05-15 | Lundbeck & Co As H | Verfahren zur herstellung von citalopram |
| NL1017417C1 (nl) | 2000-03-03 | 2001-03-16 | Lundbeck & Co As H | Werkwijze voor de bereiding van Citalopram. |
| NL1017500C1 (nl) | 2000-03-13 | 2001-04-26 | Lundbeck & Co As H | Werkwijze voor de bereiding van Citalopram. |
| AR032455A1 (es) | 2000-05-12 | 2003-11-12 | Lundbeck & Co As H | Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva |
| JP2005510518A (ja) * | 2001-11-08 | 2005-04-21 | セプラコール， インク． | シタロプラムのデスメチル代謝産物及びジデスメチル代謝産物の濃縮された鏡像異性体を用いてうつ病及び他のｃｎｓ障害を治療する方法 |
| US7078541B2 (en) * | 2002-02-07 | 2006-07-18 | Galileo Pharmaceuticals, Inc. | Benzofuran derivatives |
| AR040970A1 (es) | 2002-08-12 | 2005-04-27 | Lundbeck & Co As H | Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram |
| TR200504022T1 (tr) * | 2003-03-24 | 2006-08-21 | Hetero Drugs Limited | (S)-sitalopram oksalatın yeni sıvı kristal formları. |
| US20090018351A1 (en) * | 2003-11-12 | 2009-01-15 | Dr. Reddy's Laboratories, Inc. | Preparation of escitalopram |
| TWI339651B (en) | 2004-02-12 | 2011-04-01 | Lundbeck & Co As H | Method for the separation of intermediates which may be used for the preparation of escitalopram |
| US8615368B2 (en) * | 2005-03-10 | 2013-12-24 | Gen-Probe Incorporated | Method for determining the amount of an analyte in a sample |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1143702A (hu) | 1965-03-18 | |||
| GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| GB8419963D0 (en) | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
| GB8814057D0 (en) | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| US5296507A (en) | 1990-09-06 | 1994-03-22 | H.Lundbeck A/S | Treatment of cerbrovascular disorders |
| DE19626659A1 (de) | 1996-07-03 | 1998-01-08 | Basf Ag | Verfahren zur Herstellung von Phthaliden |
| DE19627697A1 (de) | 1996-07-10 | 1998-01-15 | Basf Ag | Verfahren zur Herstellung von Phthaliden |
| ES2148120T3 (es) | 1997-07-08 | 2002-01-16 | Lundbeck & Co As H | Metodo para la preparacion de citalopram. |
| UA62985C2 (en) * | 1997-11-10 | 2004-01-15 | Lunnbeck As H | A method for the preparation of citalopram |
| ES2149734T3 (es) | 1997-11-11 | 2003-02-16 | Lundbeck & Co As H | Metodo para la preparacion de citalopram. |
| CN1129592C (zh) | 1998-10-20 | 2003-12-03 | H·隆德贝克有限公司 | 制备西酞普兰的方法 |
| SI1140886T1 (en) | 1998-12-23 | 2003-08-31 | H. Lundbeck A/S | Method for the preparation of 5-cyanophthalide |
| AR022329A1 (es) | 1999-01-29 | 2002-09-04 | Lundbeck & Co As H | Metodo para la preparacion de 5-cianoftalida |
| ATE237604T1 (de) | 1999-04-14 | 2003-05-15 | Lundbeck & Co As H | Verfahren zur herstellung von citalopram |
| ITMI991581A1 (it) | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | Metodo per la preparazione di citalopram |
| ITMI991579A1 (it) | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | Metodo per la preparazione di citalopram |
| EP1228056B1 (en) | 1999-10-25 | 2004-09-22 | H. Lundbeck A/S | Method for the preparation of citalopram |
| AR026063A1 (es) | 1999-11-01 | 2002-12-26 | Lundbeck & Co As H | Metodo para la preparacion de 5-carboxiftalida. |
| US6310222B1 (en) * | 1999-11-01 | 2001-10-30 | Sumika Fine Chemicals Co., Ltd. | Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate |
| EA004742B1 (ru) * | 1999-12-28 | 2004-08-26 | Х.Лундбекк А/С | Способ получения циталопрама |
| JP2003519218A (ja) * | 1999-12-30 | 2003-06-17 | ハー・ルンドベック・アクチエゼルスカベット | シタロプラムの製造方法 |
| SI1254129T1 (en) | 2000-01-14 | 2004-02-29 | H. Lundbeck A/S | Method for the preparation of 5-cyanophthalide |
| IT1317729B1 (it) | 2000-01-18 | 2003-07-15 | Norpharma S P A | Procedimento per la preparazione della 5-carbossiftalide. |
| US6433196B1 (en) | 2000-02-17 | 2002-08-13 | Sumika Fine Chemicals Co., Ltd. | Production method of citalopram, intermediate therefor and production method of the intermediate |
| IES20010143A2 (en) * | 2000-02-24 | 2001-07-25 | Lundbeck & Co As H | Method for the preparation of citalopram |
| NL1017415C1 (nl) | 2000-02-24 | 2001-05-18 | Lundbeck & Co As H | Werkwijze voor de bereiding van Citalopram. |
| NL1017417C1 (nl) * | 2000-03-03 | 2001-03-16 | Lundbeck & Co As H | Werkwijze voor de bereiding van Citalopram. |
| GB0005477D0 (en) | 2000-03-07 | 2000-04-26 | Resolution Chemicals Limited | Process for the preparation of citalopram |
| CN1429219A (zh) * | 2000-03-13 | 2003-07-09 | H·隆德贝克有限公司 | 制备西酞普兰的方法 |
| NL1017500C1 (nl) * | 2000-03-13 | 2001-04-26 | Lundbeck & Co As H | Werkwijze voor de bereiding van Citalopram. |
| WO2001068630A1 (en) * | 2000-03-14 | 2001-09-20 | H. Lundbeck A/S | Method for the preparation of citalopram |
| TR200202168T2 (tr) * | 2000-03-16 | 2002-12-23 | H. Lundbeck A/S | 5-Siyano-1-(4-Florofenil)-1,3-Dihidroizobenzofuranların preparasyon metodu |
| AR032455A1 (es) * | 2000-05-12 | 2003-11-12 | Lundbeck & Co As H | Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva |
| BR0106976A (pt) | 2000-07-06 | 2002-07-23 | Lundbeck & Co As H | Método para a preparação de citalopram |
| IL144816A (en) | 2000-08-18 | 2005-09-25 | Lundbeck & Co As H | Method for the preparation of citalopram |
| SG167655A1 (en) | 2000-12-22 | 2011-01-28 | Lundbeck & Co As H | Method for the preparation of pure citalopram |
| JP2003519121A (ja) | 2000-12-28 | 2003-06-17 | ハー・ルンドベック・アクチエゼルスカベット | 純粋なシタロプラムの製造方法 |
-
2001
- 2001-03-09 NZ NZ521204A patent/NZ521204A/en unknown
- 2001-03-09 PL PL01357022A patent/PL357022A1/xx not_active Application Discontinuation
- 2001-03-09 AU AU2001239210A patent/AU2001239210A1/en not_active Abandoned
- 2001-03-09 HU HU0300273A patent/HUP0300273A2/hu unknown
- 2001-03-09 EA EA200200968A patent/EA200200968A1/ru unknown
- 2001-03-09 SK SK1452-2002A patent/SK14522002A3/sk unknown
- 2001-03-09 BR BR0109364-9A patent/BR0109364A/pt not_active IP Right Cessation
- 2001-03-09 EP EP01913735A patent/EP1265881A1/en not_active Withdrawn
- 2001-03-09 TR TR2002/02195T patent/TR200202195T2/xx unknown
- 2001-03-09 WO PCT/DK2001/000159 patent/WO2001068629A1/en not_active Application Discontinuation
- 2001-03-09 KR KR1020027012044A patent/KR20020080485A/ko not_active Application Discontinuation
- 2001-03-09 CA CA002402553A patent/CA2402553A1/en not_active Abandoned
- 2001-03-09 CZ CZ20023100A patent/CZ20023100A3/cs unknown
- 2001-03-09 CN CN01809125A patent/CN1427835A/zh active Pending
- 2001-03-09 JP JP2001567721A patent/JP2003527385A/ja not_active Withdrawn
- 2001-03-09 MX MXPA02008684A patent/MXPA02008684A/es unknown
- 2001-03-09 IL IL15156601A patent/IL151566A0/xx unknown
-
2002
- 2002-08-27 IS IS6530A patent/IS6530A/is unknown
- 2002-09-02 BG BG107046A patent/BG107046A/xx unknown
- 2002-09-10 US US10/242,804 patent/US6864379B2/en not_active Expired - Fee Related
- 2002-09-12 NO NO20024352A patent/NO20024352L/no not_active Application Discontinuation
- 2002-09-18 HR HRP20020758 patent/HRP20020758A2/hr not_active Application Discontinuation
-
2004
- 2004-08-13 US US10/917,667 patent/US20050020670A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EA200200968A1 (ru) | 2003-02-27 |
| IS6530A (is) | 2002-08-27 |
| IL151566A0 (en) | 2003-04-10 |
| PL357022A1 (en) | 2004-07-12 |
| US6864379B2 (en) | 2005-03-08 |
| NO20024352L (no) | 2002-10-08 |
| NO20024352D0 (no) | 2002-09-12 |
| HRP20020758A2 (en) | 2004-12-31 |
| CN1427835A (zh) | 2003-07-02 |
| WO2001068629A1 (en) | 2001-09-20 |
| CA2402553A1 (en) | 2001-09-20 |
| KR20020080485A (ko) | 2002-10-23 |
| MXPA02008684A (es) | 2003-02-24 |
| JP2003527385A (ja) | 2003-09-16 |
| AU2001239210A1 (en) | 2001-09-24 |
| US20050020670A1 (en) | 2005-01-27 |
| BG107046A (en) | 2003-05-30 |
| US20030083509A1 (en) | 2003-05-01 |
| CZ20023100A3 (cs) | 2003-02-12 |
| BR0109364A (pt) | 2002-12-24 |
| EP1265881A1 (en) | 2002-12-18 |
| TR200202195T2 (tr) | 2002-12-23 |
| SK14522002A3 (sk) | 2003-03-04 |
| NZ521204A (en) | 2004-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0104856A2 (hu) | Eljárás 5-cianoftalid előállítására | |
| HUP0300273A2 (hu) | Eljárás 5-szubsztituált 1-(4-fluorfenil)-1,3-dihidroizobenzofurán-származékok lépésenkénti alkilezésére | |
| HUP0103417A2 (hu) | Eljárás citalopram előállítására | |
| HUP0003177A2 (hu) | Eljárás citalopram előállítására és a használt köztitermékek | |
| HUP0103235A2 (hu) | Eljárás citalopram előállítására | |
| BG107120A (en) | Novel, slow-acting betamimetics, a method for their production and their use as medicaments | |
| TR200202185T2 (tr) | Sitalopramın kristalin bazı. | |
| AR029604A2 (es) | Intermediarios para la preparacion de citalopram y composicion farmaceutica antidepresiva que comprende el citalopram preparado | |
| AR029597A1 (es) | Metodo para la preparacion de citalopram | |
| HUP0300134A2 (en) | Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans | |
| HUP0300343A2 (hu) | Eljárás 5-cianoftalid előállítására | |
| HUP0203635A2 (hu) | Eljárás citalopram előállítására | |
| TR200708792T1 (tr) | Kristal esitalopram bazı ve esitalopram içeren ağızda dağılan tabletler | |
| NO20014211L (no) | Fremgangsmåte ved fremstilling av taxaner fra 10- deacetylbaccatin III | |
| DE60239044D1 (de) | Phthalimidyl-azofarbstoffe, verfahren zu deren herstellung und deren verwendung | |
| HUP0203840A2 (en) | Method for the preparation of citalopram | |
| HUP0300274A2 (hu) | Eljárás citalopram előállítására | |
| HUP0301942A2 (hu) | Eljárás citalopram elżállítására | |
| DE60032827D1 (de) | Verfahren und Oxazolidin Zwischenprodukt zur Herstellung von Taxanen | |
| HUP0300178A2 (en) | Method for the preparation of citalopram | |
| PT786459E (pt) | Processo para a preparacao de um enantiomero de alcool heterobiciclico | |
| JP2003528970A5 (hu) | ||
| AR011066A1 (es) | Procesos para la sintesis de alfa gal(1-4) beta gal (1-4)glc-or. | |
| SE0002166L (sv) | Fastfas syntes av cyaninfärgämnen | |
| KR920009781A (ko) | α－[(디알킬아미노) 치환 메틸렌]－β－옥소－(치환) 프로판니트릴 및 이의 제조방법 |